Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285

doi:10.1016/j.cclet.2017.01.003

中国化学快报 ›› 2017, Vol. 28 ›› Issue (06) : 1220-1227. DOI: 10.1016/j.cclet.2017.01.003

论著

Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285

{{article.zuoZhe_CN}}

作者信息 +

Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285

{{article.zuoZhe_EN}}

Author information +

History +

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2017, 28(06): 1220-1227 https://doi.org/10.1016/j.cclet.2017.01.003

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2017, 28(06): 1220-1227 https://doi.org/10.1016/j.cclet.2017.01.003

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

基金

版权

PDF(911 KB)

Accesses

Citation

Detail

段落导航

选择文件类型/文献管理软件名称

选择包含的内容

本文亮点

HeighLight

摘要

Abstract

关键词

Key words

引用本文

{{custom_sec.title}}

{{custom_sec.title}}

参考文献

参考文献

{{custom_fnGroup.title_cn}}

脚注

{{custom_ack.title_cn}}

基金

版权

Published
2017-06-22
Issue Date
2017-06-22